See also this year's filing and all EDGAR filings for this company.
PDF Report 0001070336_2013_Achillion_Pharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001070336, Achillion Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 67,867,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,247,000 |
| 3 | remainder_Assets | 12,416,000 |
| 4 | LiabilitiesCurrent | 9,136,000 |
| 5 | LiabilitiesNoncurrent | 347,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 10,901,000 |
| 9 | ResearchAndDevelopmentExpense | 38,999,000 |
| 10 | remainder_Expenses | 68,000 |
| 11 | remainder_Revenues | 2,607,000 |
| 12 | remainder_NetIncome | 234,000 |
| 13 | remainder_ComprehensiveNetIncome | 39,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 81,530,000 |
| 1 | Liabilities | 9,483,000 |
| 2 | Expenses | 49,968,000 |
| 3 | Revenues | 2,607,000 |
| 4 | StockholdersEquity | 72,047,000 |
| 5 | NetIncome | -47,127,000 |
| 6 | ComprehensiveNetIncome | -47,107,500 |
| 7 | BaseVar | 71,930,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.42 |
| 9 | EconomicCapitalRatio | 3.30 |
Edgar->Model Mapping
Feature Distribution
Change over Time
